Extended Pancreaticoduodenectomy with Vascular Resection for Pancreatic Cancer: A Systematic Review

This publication has 42 references indexed in Scilit:

• A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer
  British Journal of Cancer, 2009
• Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000–01 FFCD/SFRO study
  Annals of Oncology, 2008
• Survival After Pancreatectomy With Major Arterial Resection and Reconstruction
  Annals of Surgical Oncology, 2008
• Postoperative Morbidity and Long-term Survival After Pancreaticoduodenectomy With Superior Mesenterico−Portal Vein Resection
  Journal of Gastrointestinal Surgery, 2006
• One Thousand Consecutive Pancreaticoduodenectomies
  Annals of Surgery, 2006
• Systematic review of outcome of synchronous portal–superior mesenteric vein resection during pancreatectomy for cancer
  British Journal of Surgery, 2006
• A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma
  Surgery, 2005
• Pancreaticoduodenectomy in the Presence of Superior Mesenteric Venous Obstruction
  Journal of Gastrointestinal Surgery, 2005
• Pancreaticoduodenectomy with vascular resection: margin status and survival duration
  Journal of Gastrointestinal Surgery, 2004
• Reevaluation of the Indications for Radical Pancreatectomy to Treat Pancreatic Carcinoma: Is Portal Vein Infiltration a Contraindication?
  Surgery Today, 2002